Search research articles
Contact Us
Filters
Showing results (561-570 of 603) with videos related to
Page
of 61
Sort By:
Journal of Neurosurgery. Spine
|
September 13, 2024
Do obese patients undergoing surgery for grade 1 spondylolisthesis have worse outcomes at 5 years' follow-up? A QOD study
Samer G Zammar, Vardhaan S Ambati, Timothy J Yee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 29, 2017
B-Cell Lymphoma Patient-Derived Xenograft Models Enable Drug Discovery and Are a Platform for Personalized Therapy
Leo Zhang, Krystle Nomie, Hui Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 14, 2015
Mutational landscape of gastric adenocarcinoma in Chinese: implications for prognosis and therapy
Kexin Chen, Da Yang, Xiangchun Li, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
October 12, 2021
The safety of activated eptacog beta in the management of bleeding episodes and perioperative haemostasis in adult and paediatric haemophilia patients with inhibitors
Miguel Escobar, Giancarlo Castaman, Santiago Bonanad Boix, et al.
The Lancet. Haematology
|
June 6, 2024
Response-adapted ultra-low-dose 4 Gy radiation as definitive therapy of gastric MALT lymphoma: a single-centre, pilot trial
Jillian R Gunther, Jie Xu, Manoop S Bhutani, et al.
The New England Journal of Medicine
|
February 22, 2023
Two-Year Outcomes of Valoctocogene Roxaparvovec Therapy for Hemophilia A
Johnny Mahlangu, Radoslaw Kaczmarek, Annette von Drygalski, et al.
Journal of Medicinal Chemistry
|
October 14, 2014
Potent nonimmunosuppressive cyclophilin inhibitors with improved pharmaceutical properties and decreased transporter inhibition
Jiping Fu, Meiliana Tjandra, Christopher Becker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 13, 2016
Characteristics of Patients Who Survived < 3 Months or > 2 Years After Surgery for Spinal Metastases: Can We Avoid Inappropriate Patient Selection?
Jorrit-Jan Verlaan, David Choi, Anne Versteeg, et al.
The New England Journal of Medicine
|
December 9, 2014
Carfilzomib, lenalidomide, and dexamethasone for relapsed multiple myeloma
A Keith Stewart, S Vincent Rajkumar, Meletios A Dimopoulos, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
April 27, 2022
Eptacog beta efficacy and safety in the treatment and control of bleeding in paediatric subjects (<12 years) with haemophilia A or B with inhibitors
Steven W Pipe, Cédric Hermans, Meera Chitlur, et al.
Page
of 61
Search research articles
Search
Showing results (561-570 of 603) with videos related to
Sort By:
Page
of 61
Journal of Neurosurgery. Spine
|
September 13, 2024
Do obese patients undergoing surgery for grade 1 spondylolisthesis have worse outcomes at 5 years' follow-up? A QOD study
Samer G Zammar, Vardhaan S Ambati, Timothy J Yee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 29, 2017
B-Cell Lymphoma Patient-Derived Xenograft Models Enable Drug Discovery and Are a Platform for Personalized Therapy
Leo Zhang, Krystle Nomie, Hui Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 14, 2015
Mutational landscape of gastric adenocarcinoma in Chinese: implications for prognosis and therapy
Kexin Chen, Da Yang, Xiangchun Li, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
October 12, 2021
The safety of activated eptacog beta in the management of bleeding episodes and perioperative haemostasis in adult and paediatric haemophilia patients with inhibitors
Miguel Escobar, Giancarlo Castaman, Santiago Bonanad Boix, et al.
The Lancet. Haematology
|
June 6, 2024
Response-adapted ultra-low-dose 4 Gy radiation as definitive therapy of gastric MALT lymphoma: a single-centre, pilot trial
Jillian R Gunther, Jie Xu, Manoop S Bhutani, et al.
The New England Journal of Medicine
|
February 22, 2023
Two-Year Outcomes of Valoctocogene Roxaparvovec Therapy for Hemophilia A
Johnny Mahlangu, Radoslaw Kaczmarek, Annette von Drygalski, et al.
Journal of Medicinal Chemistry
|
October 14, 2014
Potent nonimmunosuppressive cyclophilin inhibitors with improved pharmaceutical properties and decreased transporter inhibition
Jiping Fu, Meiliana Tjandra, Christopher Becker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 13, 2016
Characteristics of Patients Who Survived < 3 Months or > 2 Years After Surgery for Spinal Metastases: Can We Avoid Inappropriate Patient Selection?
Jorrit-Jan Verlaan, David Choi, Anne Versteeg, et al.
The New England Journal of Medicine
|
December 9, 2014
Carfilzomib, lenalidomide, and dexamethasone for relapsed multiple myeloma
A Keith Stewart, S Vincent Rajkumar, Meletios A Dimopoulos, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
April 27, 2022
Eptacog beta efficacy and safety in the treatment and control of bleeding in paediatric subjects (<12 years) with haemophilia A or B with inhibitors
Steven W Pipe, Cédric Hermans, Meera Chitlur, et al.
Page
of 61